Monsanto Company (NYSE:MON) – Stock analysts at Jefferies Group upped their FY2017 earnings per share estimates for Monsanto Company in a research note issued on Wednesday, Zacks Investment Research reports. Jefferies Group analyst L. Alexander now expects that the basic materials company will post earnings of $4.90 per share for the year, up from their prior estimate of $4.65. Jefferies Group currently has a “Buy” rating and a $128.00 target price on the stock. Jefferies Group also issued estimates for Monsanto Company’s FY2018 earnings at $5.40 EPS, FY2019 earnings at $6.50 EPS and FY2020 earnings at $7.45 EPS.
Monsanto Company (NYSE:MON) last issued its quarterly earnings results on Wednesday, April 5th. The basic materials company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.40. The business earned $5.07 billion during the quarter, compared to the consensus estimate of $4.73 billion. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The company’s quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the company earned $2.42 earnings per share. TRADEMARK VIOLATION WARNING: This report was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.chaffeybreeze.com/2017/04/21/jefferies-group-analysts-increase-earnings-estimates-for-monsanto-company-mon-updated.html.
Other equities analysts also recently issued reports about the company. Vetr raised Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 target price for the company in a research note on Wednesday, March 15th. BMO Capital Markets reissued a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research note on Wednesday, April 5th. Zacks Investment Research downgraded Monsanto Company from a “buy” rating to a “hold” rating in a research note on Tuesday, February 28th. Royal Bank of Canada reissued a “hold” rating and set a $118.00 target price on shares of Monsanto Company in a research note on Tuesday, March 28th. Finally, Citigroup Inc reissued a “neutral” rating and set a $125.00 target price (up from $122.00) on shares of Monsanto Company in a research note on Friday, April 14th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $118.94.
Shares of Monsanto Company (NYSE:MON) traded down 0.0703% during midday trading on Thursday, reaching $115.6387. The company’s stock had a trading volume of 1,390,366 shares. Monsanto Company has a 12-month low of $88.76 and a 12-month high of $116.60. The company has a market cap of $50.74 billion, a P/E ratio of 26.6020 and a beta of 0.93. The stock’s 50-day moving average price is $114.50 and its 200-day moving average price is $107.42.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Investors of record on Friday, April 7th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Wednesday, April 5th. Monsanto Company’s payout ratio is currently 58.86%.
In other Monsanto Company news, CEO Michael K. Stern sold 5,670 shares of the firm’s stock in a transaction dated Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total value of $623,700.00. Following the transaction, the chief executive officer now directly owns 20,534 shares of the company’s stock, valued at $2,258,740. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Steven Mizell sold 13,700 shares of the firm’s stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $116.11, for a total value of $1,590,707.00. Following the completion of the transaction, the executive vice president now directly owns 50,295 shares in the company, valued at $5,839,752.45. The disclosure for this sale can be found here. Insiders sold 249,540 shares of company stock worth $28,947,034 in the last quarter. 0.79% of the stock is owned by insiders.
Several hedge funds have recently made changes to their positions in the company. State Street Corp raised its stake in shares of Monsanto Company by 4.6% in the fourth quarter. State Street Corp now owns 19,919,384 shares of the basic materials company’s stock valued at $2,095,723,000 after buying an additional 880,865 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in shares of Monsanto Company by 1.3% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 11,359,066 shares of the basic materials company’s stock valued at $1,160,897,000 after buying an additional 140,637 shares in the last quarter. Northern Trust Corp raised its stake in shares of Monsanto Company by 1.2% in the third quarter. Northern Trust Corp now owns 6,426,572 shares of the basic materials company’s stock valued at $656,795,000 after buying an additional 76,133 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Monsanto Company by 506.6% in the fourth quarter. Franklin Resources Inc. now owns 5,040,923 shares of the basic materials company’s stock valued at $530,355,000 after buying an additional 4,209,910 shares in the last quarter. Finally, Independent Franchise Partners LLP raised its stake in shares of Monsanto Company by 1.9% in the third quarter. Independent Franchise Partners LLP now owns 4,129,184 shares of the basic materials company’s stock valued at $422,002,000 after buying an additional 78,486 shares in the last quarter. 75.18% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.